Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational national tolerance study of GRAZAX in routine care for grass pollen allergic rhinitis
2007-003772-20Phase 4Completed
- Sponsor
- Laboratoire Allerbio
- Start
- Aug 2007
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of phleum pratense allergen extract in allergic rhinitis (AR), sponsored by Laboratoire Allerbio. Primary endpoint: Tolerance (adverse events and serious adverse events). Started Aug 2007; status: completed.
02
Drugs
phleum pratense allergen extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on 2007-003772-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003772-20.